Cargando…
New Antibacterial Secondary Metabolites from a Marine-Derived Talaromyces sp. Strain BTBU20213036
New polyketide-derived oligophenalenone dimers, bacillisporins K and L (1 and 2) and xanthoradone dimer rugulosin D (3), together with four known compounds, bacillisporin B (4), macrosporusone D (5), rugulosin A and penicillide (6 and 7), were isolated from the marine-derived fungus Talaromyces sp....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868179/ https://www.ncbi.nlm.nih.gov/pubmed/35203824 http://dx.doi.org/10.3390/antibiotics11020222 |
_version_ | 1784656203909955584 |
---|---|
author | Song, Fuhang Dong, Yifei Wei, Shangzhu Zhang, Xinwan Zhang, Kai Xu, Xiuli |
author_facet | Song, Fuhang Dong, Yifei Wei, Shangzhu Zhang, Xinwan Zhang, Kai Xu, Xiuli |
author_sort | Song, Fuhang |
collection | PubMed |
description | New polyketide-derived oligophenalenone dimers, bacillisporins K and L (1 and 2) and xanthoradone dimer rugulosin D (3), together with four known compounds, bacillisporin B (4), macrosporusone D (5), rugulosin A and penicillide (6 and 7), were isolated from the marine-derived fungus Talaromyces sp. BTBU20213036. Their structures were determined by detailed analysis of HRESIMS, 1D and 2D NMR data, and the absolute configurations were determined on the basis of calculated and experimental electronic circular dichroism (ECD). The antibacterial and antifungal activities of these compounds were tested against Gram-positive—Staphylococcus aureus, Gram-negative—Escherichia coli, and fungal strain—Candida albicans. These compounds showed potential inhibitory effects against S. aureus with minimum inhibitory concentrations ranging from 0.195 to 100 µg/mL. |
format | Online Article Text |
id | pubmed-8868179 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88681792022-02-25 New Antibacterial Secondary Metabolites from a Marine-Derived Talaromyces sp. Strain BTBU20213036 Song, Fuhang Dong, Yifei Wei, Shangzhu Zhang, Xinwan Zhang, Kai Xu, Xiuli Antibiotics (Basel) Article New polyketide-derived oligophenalenone dimers, bacillisporins K and L (1 and 2) and xanthoradone dimer rugulosin D (3), together with four known compounds, bacillisporin B (4), macrosporusone D (5), rugulosin A and penicillide (6 and 7), were isolated from the marine-derived fungus Talaromyces sp. BTBU20213036. Their structures were determined by detailed analysis of HRESIMS, 1D and 2D NMR data, and the absolute configurations were determined on the basis of calculated and experimental electronic circular dichroism (ECD). The antibacterial and antifungal activities of these compounds were tested against Gram-positive—Staphylococcus aureus, Gram-negative—Escherichia coli, and fungal strain—Candida albicans. These compounds showed potential inhibitory effects against S. aureus with minimum inhibitory concentrations ranging from 0.195 to 100 µg/mL. MDPI 2022-02-10 /pmc/articles/PMC8868179/ /pubmed/35203824 http://dx.doi.org/10.3390/antibiotics11020222 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Song, Fuhang Dong, Yifei Wei, Shangzhu Zhang, Xinwan Zhang, Kai Xu, Xiuli New Antibacterial Secondary Metabolites from a Marine-Derived Talaromyces sp. Strain BTBU20213036 |
title | New Antibacterial Secondary Metabolites from a Marine-Derived Talaromyces sp. Strain BTBU20213036 |
title_full | New Antibacterial Secondary Metabolites from a Marine-Derived Talaromyces sp. Strain BTBU20213036 |
title_fullStr | New Antibacterial Secondary Metabolites from a Marine-Derived Talaromyces sp. Strain BTBU20213036 |
title_full_unstemmed | New Antibacterial Secondary Metabolites from a Marine-Derived Talaromyces sp. Strain BTBU20213036 |
title_short | New Antibacterial Secondary Metabolites from a Marine-Derived Talaromyces sp. Strain BTBU20213036 |
title_sort | new antibacterial secondary metabolites from a marine-derived talaromyces sp. strain btbu20213036 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868179/ https://www.ncbi.nlm.nih.gov/pubmed/35203824 http://dx.doi.org/10.3390/antibiotics11020222 |
work_keys_str_mv | AT songfuhang newantibacterialsecondarymetabolitesfromamarinederivedtalaromycesspstrainbtbu20213036 AT dongyifei newantibacterialsecondarymetabolitesfromamarinederivedtalaromycesspstrainbtbu20213036 AT weishangzhu newantibacterialsecondarymetabolitesfromamarinederivedtalaromycesspstrainbtbu20213036 AT zhangxinwan newantibacterialsecondarymetabolitesfromamarinederivedtalaromycesspstrainbtbu20213036 AT zhangkai newantibacterialsecondarymetabolitesfromamarinederivedtalaromycesspstrainbtbu20213036 AT xuxiuli newantibacterialsecondarymetabolitesfromamarinederivedtalaromycesspstrainbtbu20213036 |